Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD38 expression by plasma cells in extramedullary multiple myeloma.
Notarfranchi L, Accardi F, Mancini C, Martella E, Bonomini S, Segreto R, Vescovini R, Palma ABD, Sammarelli G, Todaro G, Storti P, Burroughs-Garcia J, Iannozzi NT, Raimondi V, Lungu O, Ricci S, Craviotto L, Giuliani N. Notarfranchi L, et al. Among authors: mancini c. Haematologica. 2024 Apr 1;109(4):1297-1300. doi: 10.3324/haematol.2023.284169. Haematologica. 2024. PMID: 37941401 Free PMC article. No abstract available.
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells.
Storti P, Toscani D, Airoldi I, Marchica V, Maiga S, Bolzoni M, Fiorini E, Campanini N, Martella E, Mancini C, Guasco D, Ferri V, Donofrio G, Aversa F, Amiot M, Giuliani N. Storti P, et al. Among authors: mancini c. Haematologica. 2016 Mar;101(3):e107-10. doi: 10.3324/haematol.2015.133736. Epub 2015 Dec 11. Haematologica. 2016. PMID: 26659917 Free PMC article. No abstract available.
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?
Marchica V, Accardi F, Storti P, Mancini C, Martella E, Dalla Palma B, Bolzoni M, Todoerti K, Marcatti M, Schifano C, Bonomini S, Sammarelli G, Neri A, Ponzoni M, Aversa F, Giuliani N. Marchica V, et al. Among authors: mancini c. Int J Hematol. 2017 Jan;105(1):104-108. doi: 10.1007/s12185-016-2104-1. Epub 2016 Oct 3. Int J Hematol. 2017. PMID: 27699576
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation.
Costa F, Toscani D, Chillemi A, Quarona V, Bolzoni M, Marchica V, Vescovini R, Mancini C, Martella E, Campanini N, Schifano C, Bonomini S, Accardi F, Horenstein AL, Aversa F, Malavasi F, Giuliani N. Costa F, et al. Among authors: mancini c. Oncotarget. 2017 May 16;8(34):56598-56611. doi: 10.18632/oncotarget.17896. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915615 Free PMC article.
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
Accardi F, Marchica V, Mancini C, Maredi E, Racano C, Notarfranchi L, Martorana D, Storti P, Martella E, Palma BD, Craviotto L, Filippo M, Percesepe A, Aversa F, Giuliani N. Accardi F, et al. Among authors: mancini c. Hematol Rep. 2018 Apr 3;10(1):7457. doi: 10.4081/hr.2018.7457. eCollection 2018 Mar 2. Hematol Rep. 2018. PMID: 29721253 Free PMC article.
The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors.
Toscani D, Palumbo C, Dalla Palma B, Ferretti M, Bolzoni M, Marchica V, Sena P, Martella E, Mancini C, Ferri V, Costa F, Accardi F, Craviotto L, Aversa F, Giuliani N. Toscani D, et al. Among authors: mancini c. J Bone Miner Res. 2016 Apr;31(4):815-27. doi: 10.1002/jbmr.2741. Epub 2015 Dec 14. J Bone Miner Res. 2016. PMID: 26551485 Free article.
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.
Bolzoni M, Chiu M, Accardi F, Vescovini R, Airoldi I, Storti P, Todoerti K, Agnelli L, Missale G, Andreoli R, Bianchi MG, Allegri M, Barilli A, Nicolini F, Cavalli A, Costa F, Marchica V, Toscani D, Mancini C, Martella E, Dall'Asta V, Donofrio G, Aversa F, Bussolati O, Giuliani N. Bolzoni M, et al. Among authors: mancini c. Blood. 2016 Aug 4;128(5):667-79. doi: 10.1182/blood-2016-01-690743. Epub 2016 Jun 6. Blood. 2016. PMID: 27268090 Free article.
Hairy cell leukaemia mimicking multiple myeloma.
Notarfranchi L, Russo F, Re F, Mancini C, Martella E, Falini B, Aversa F, Tiacci E. Notarfranchi L, et al. Among authors: mancini c. Lancet Oncol. 2019 Mar;20(3):e187. doi: 10.1016/S1470-2045(18)30609-0. Lancet Oncol. 2019. PMID: 30842062 No abstract available.
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.
Marchica V, Toscani D, Corcione A, Bolzoni M, Storti P, Vescovini R, Ferretti E, Dalla Palma B, Vicario E, Accardi F, Mancini C, Martella E, Ribatti D, Vacca A, Pistoia V, Giuliani N. Marchica V, et al. Among authors: mancini c. Cancers (Basel). 2019 Mar 6;11(3):321. doi: 10.3390/cancers11030321. Cancers (Basel). 2019. PMID: 30845779 Free PMC article.
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy.
Marchica V, Franceschi V, Vescovini R, Storti P, Vicario E, Toscani D, Zorzoli A, Airoldi I, Dalla Palma B, Campanini N, Martella E, Mancini C, Costa F, Donofrio G, Giuliani N. Marchica V, et al. Among authors: mancini c. J Hematol Oncol. 2020 Jul 11;13(1):89. doi: 10.1186/s13045-020-00919-w. J Hematol Oncol. 2020. PMID: 32653014 Free PMC article.
441 results